What is the maximum recommended dose of guaifenesin (expectorant) for an 8-year-old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Guaifenesin Dose for 8-Year-Old Children

For an 8-year-old child, the maximum dose of guaifenesin is 1200 mg per day, administered as 200-400 mg every 4 hours (not to exceed 6 doses in 24 hours) for immediate-release formulations, or 600 mg every 12 hours for extended-release formulations.

Dosing Regimens

Immediate-Release Formulations

  • Standard dosing: 200-400 mg every 4 hours 1
  • Maximum frequency: Up to 6 times daily 1
  • Daily maximum: 1200-2400 mg total per day 1
  • The flexible dosing range allows titration to achieve adequate plasma concentrations while maintaining safety 1

Extended-Release Formulations

  • Dosing: 600 mg every 12 hours 2
  • Maximum daily dose: 1200 mg per day 2
  • Extended-release formulations provide equivalent steady-state exposure to immediate-release products while offering more convenient twice-daily dosing 2
  • These formulations maintain therapeutic effect over 12 hours, eliminating the need for frequent dosing 2, 1

Practical Administration Considerations

  • Dose rounding: The dose can be rounded by up to 15% for ease of home administration, making it more practical for caregivers 3
  • Combination products: When using guaifenesin-containing combination products, ensure the guaifenesin component does not exceed the maximum daily limit to avoid excessive dosing 3
  • Food effects: For extended-release formulations, food delays time to maximum concentration but does not affect overall bioavailability, so these can be taken with or without food 2

Safety Profile

  • Guaifenesin has a well-established and favorable safety profile in pediatric populations 1
  • The documented side effects are generally mild 4
  • Multiple daily doses of immediate-release formulations are needed to maintain 24-hour therapeutic effect 1

Clinical Context

  • Guaifenesin acts as a mucoactive drug, loosening mucus in airways and making coughs more productive 1
  • It is indicated for relief of wet cough and chest congestion due to common cold and acute tracheobronchitis 5
  • Clinical efficacy has been demonstrated in pediatric patients for treatment of cough, expectoration, nasal congestion, and runny nose 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.